Kazuo Fujihara Selected Research

Kazuo Fujihara Research Topics

Disease

104	Neuromyelitis Optica (Devic's Disease) 06/2024 - 04/2004
45	Multiple Sclerosis 11/2023 - 11/2002
27	Optic Neuritis (Retrobulbar Neuritis) 12/2023 - 01/2011
23	Demyelinating Diseases (Demyelinating Disease) 12/2023 - 08/2007
11	Myelitis 01/2023 - 11/2006
10	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2009
7	Infections 05/2022 - 01/2012
5	Inflammation (Inflammations) 01/2023 - 03/2011
5	Leukocytosis (Pleocytosis) 01/2019 - 11/2007
5	Necrosis 06/2013 - 10/2004
4	Encephalomyelitis (Myeloencephalitis) 01/2023 - 12/2015
4	Pain (Aches) 01/2021 - 01/2012
4	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 05/2003
4	Transverse Myelitis (Necrotizing Myelitis) 01/2016 - 01/2012
3	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023 - 10/2015
3	Fatigue 01/2021 - 06/2015
3	Blindness (Hysterical Blindness) 10/2019 - 11/2006
3	Disease Progression 01/2018 - 10/2015
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2015 - 10/2004
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 02/2005 - 08/2003
2	Nasopharyngitis 06/2024 - 05/2021
2	Ganglion Cysts (Ganglion) 01/2023 - 01/2022
2	Human Influenza (Influenza) 05/2022 - 11/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2019
2	Headache (Headaches) 05/2021 - 01/2019
2	Aphasia (Dysphasia) 01/2018 - 09/2014
2	Poisoning 01/2016 - 05/2015
2	Central Nervous System Diseases (CNS Diseases) 12/2015 - 10/2015
2	Spinal Cord Diseases 03/2015 - 08/2003
2	Granuloma 03/2011 - 02/2002
2	Opticospinal Multiple Sclerosis 01/2011 - 11/2007
2	Polymyositis 11/2006 - 02/2002
2	Myositis (Idiopathic Inflammatory Myopathies) 12/2005 - 02/2002
1	COVID-19 06/2024
1	Pneumonia (Pneumonitis) 06/2024
1	Urinary Tract Infections (Urinary Tract Infection) 06/2024
1	Respiratory Insufficiency (Respiratory Failure) 06/2024
1	Viral Pneumonia 06/2024
1	Arthralgia (Joint Pain) 06/2024
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2023
1	Hypokalemia 01/2023
1	Inappropriate ADH Syndrome (SIADH) 01/2023
1	Nephrogenic Diabetes Insipidus 01/2023
1	Relapsing-Remitting Multiple Sclerosis 01/2023
1	Quadriplegia (Spastic Quadriplegia) 01/2023
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2023
1	Hepatitis E 05/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Atrophy 01/2022

Drug/Important Bio-Agent (IBA)

37	Immunoglobulin G (IgG)IBA 06/2024 - 12/2004
34	AntibodiesIBA 07/2023 - 11/2009
30	AutoantibodiesIBA 01/2023 - 12/2004
29	Myelin-Oligodendrocyte GlycoproteinIBA 12/2023 - 02/2014
22	Aquaporin 4IBA 01/2023 - 11/2010
13	Complement System Proteins (Complement)IBA 01/2023 - 06/2008
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2010
11	Aquaporins (Water Channels)IBA 01/2023 - 05/2007
9	inebilizumabIBA 06/2024 - 10/2019
8	eculizumab FDA Link 01/2023 - 01/2019
8	ChemokinesIBA 11/2016 - 08/2003
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2005
7	Oligoclonal BandsIBA 01/2018 - 06/2004
6	satralizumabIBA 02/2024 - 11/2019
6	Retinaldehyde (Retinal)IBA 01/2023 - 12/2010
6	anti-aquaporin 4 autoantibodyIBA 01/2016 - 05/2008
5	Glial Fibrillary Acidic ProteinIBA 01/2023 - 05/2008
5	SteroidsIBA 05/2022 - 12/2014
5	InterferonsIBA 06/2015 - 10/2004
5	AntigensIBA 09/2011 - 05/2007
4	Monoclonal AntibodiesIBA 02/2024 - 06/2008
4	Methylprednisolone FDA LinkGeneric 01/2020 - 05/2008
4	CytokinesIBA 11/2016 - 10/2004
3	Prednisolone (Predate)FDA LinkGeneric 04/2021 - 05/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2014
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2019 - 11/2007
3	Protons (Proton)IBA 01/2016 - 04/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015 - 10/2003
3	Therapeutic UsesIBA 12/2014 - 02/2005
3	Immunoglobulins (Immunoglobulin)IBA 11/2009 - 11/2006
3	Interferon-alpha (Interferon Alfa)IBA 02/2005 - 08/2003
2	Rituximab (Mabthera)FDA Link 01/2021 - 07/2011
2	EnzymesIBA 01/2020 - 08/2007
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 03/2014
2	Myelin Basic ProteinIBA 03/2017 - 05/2012
2	EpitopesIBA 10/2016 - 01/2011
2	Carbon MonoxideIBA 01/2016 - 05/2015
2	Interferon-betaIBA 02/2008 - 11/2007
1	PotassiumIBA 01/2023
1	Vasopressins (Vasopressin)IBA 01/2023
1	Dimethyl FumarateIBA 01/2023
1	ElectrolytesIBA 01/2023
1	Complement C5 (Complement 5)IBA 01/2023
1	SodiumIBA 01/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2023
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022

Therapy/Procedure

26	Therapeutics 06/2024 - 10/2003
3	Secondary Prevention 01/2023 - 01/2021
2	Immunotherapy 01/2012 - 02/2002
1	Patient Admission (Patient Admissions) 11/2023